Stock Track | Iovance Biotherapeutics Plummets 5.08% After Analysts Cut Price Targets

Stock Track03-04

Iovance Biotherapeutics, Inc. (IOVA) stock price plummeted 5.08% in the intraday trading session on Monday. The decline was likely driven by analysts lowering their price targets on the company's stock.

Truist Securities lowered its price target on Iovance Biotherapeutics from $25 to $15, while maintaining a Buy rating on the stock. This followed the company's fourth-quarter results, which prompted analysts to reevaluate their expectations.

Additionally, Chardan Capital Markets reduced its price target on Iovance Biotherapeutics from $34 to $30, although it maintained a Buy rating as well. According to analysts polled by FactSet, the company currently has an average rating of Buy and a mean price target of $20.62.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1138705215?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 00:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138705215","market":"hk","top_or_hot":-1,"title":"Stock Track | Iovance Biotherapeutics Plummets 5.08% After Analysts Cut Price Targets","media":"Stock Track","content":"<p>Iovance Biotherapeutics, Inc. (IOVA) stock price plummeted 5.08% in the intraday trading session on Monday. The decline was likely driven by analysts lowering their price targets on the company's stock.</p>\n\n<p>Truist Securities lowered its price target on Iovance Biotherapeutics from $25 to $15, while maintaining a Buy rating on the stock. This followed the company's fourth-quarter results, which prompted analysts to reevaluate their expectations.</p>\n\n<p>Additionally, Chardan Capital Markets reduced its price target on Iovance Biotherapeutics from $34 to $30, although it maintained a Buy rating as well. According to analysts polled by FactSet, the company currently has an average rating of Buy and a mean price target of $20.62.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Iovance Biotherapeutics Plummets 5.08% After Analysts Cut Price Targets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Iovance Biotherapeutics Plummets 5.08% After Analysts Cut Price Targets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-04 00:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Iovance Biotherapeutics, Inc. (IOVA) stock price plummeted 5.08% in the intraday trading session on Monday. The decline was likely driven by analysts lowering their price targets on the company's stock.</p>\n\n<p>Truist Securities lowered its price target on Iovance Biotherapeutics from $25 to $15, while maintaining a Buy rating on the stock. This followed the company's fourth-quarter results, which prompted analysts to reevaluate their expectations.</p>\n\n<p>Additionally, Chardan Capital Markets reduced its price target on Iovance Biotherapeutics from $34 to $30, although it maintained a Buy rating as well. According to analysts polled by FactSet, the company currently has an average rating of Buy and a mean price target of $20.62.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IOVA","symbol_name":"Iovance Biotherapeutics, Inc.","start_time":0,"source_url":"","article_id":"1138705215","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138705215","pubTimestamp":1741018955,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Iovance Biotherapeutics, Inc.  stock price plummeted 5.08% in the intraday trading session on Monday. The decline was likely driven by analysts lowering their price targets on the company's stock.Truist Securities lowered its price target on Iovance Biotherapeutics from $25 to $15, while maintaining a Buy rating on the stock. This followed the company's fourth-quarter results, which prompted analysts to reevaluate their expectations.Additionally, Chardan Capital Markets reduced its price target ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IOVA":"Iovance Biotherapeutics, Inc."},"translate_title":"分析师下调目标价后，Iovance Biotherapeutics股价暴跌5.08%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IOVA":1},"content_text":"Iovance Biotherapeutics, Inc. (IOVA) stock price plummeted 5.08% in the intraday trading session on Monday. The decline was likely driven by analysts lowering their price targets on the company's stock.\nTruist Securities lowered its price target on Iovance Biotherapeutics from $25 to $15, while maintaining a Buy rating on the stock. This followed the company's fourth-quarter results, which prompted analysts to reevaluate their expectations.\nAdditionally, Chardan Capital Markets reduced its price target on Iovance Biotherapeutics from $34 to $30, although it maintained a Buy rating as well. According to analysts polled by FactSet, the company currently has an average rating of Buy and a mean price target of $20.62.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1138705215","isCrawlerRequest":true}